Press Releases Year None 2026 2025 2024 2023 2022 2021 2020 2019 Oct 14, 2026 Century Therapeutics to Attend 2026 Jefferies Global Healthcare Conference in London Oct 02, 2026 Century Therapeutics' CNTY-813 Demonstrates Continued Advancement Toward the Clinic Via Nonclinical Data Presented at EASD 2026 Sep 09, 2026 Century Therapeutics Appoints Joseph Truitt to Board of Directors Aug 12, 2026 Century Therapeutics Reports Second Quarter 2026 Financial Results and Business Updates Jul 09, 2026 Century Therapeutics Selected for Oral Presentations of CNTY-813 Preclinical Data at EASD 2026 and Breakthrough T1D® Clinical & Research Congress 2026 Jun 08, 2026 New CNTY-813 Preclinical Data Demonstrate Durable Glucose Control, Immune Evasion Under Alloimmune Pressure, and Scalable Manufacturing at ADA 2026 May 13, 2026 Century Therapeutics Reports First Quarter Financial Results and Business Updates Apr 30, 2026 Century Therapeutics Selected for Oral Presentation of CNTY‑813 Preclinical Data at the American Diabetes Association 86th Scientific Sessions Mar 12, 2026 Century Therapeutics Reports Full Year 2025 Financial Results and Business Updates Feb 25, 2026 Century Therapeutics to Participate in Upcoming Investor Conferences in March Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page › Last page » Displaying 1 - 10 of 103
